Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis
"This new study provides real-world evidence for its impact on Alzheimer's disease, even though preclinical research has suggested that semaglutide may protect against neurodegene
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study
In an observational study, Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among people with type 2 diabetes.
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics
People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.
Novo’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s effects in diseases beyond type 2 diabetes and obesity.
Ozempic can even cut the risk of Alzheimer’s disease, study says
Novo Nordisk’s blockbuster drug Ozempic (NVO) is linked to yet another health benefit. This time it’s lowering the risk of Alzheimer’s disease.
3h
on MSN
Could Eating More Of This Macronutrient Be A Natural Alternative To Ozempic? What Experts Say
Some influencers are calling protein "nature's Ozempic." But can protein naturally stimulate your GLP-1 levels just like a ...
The Economist
14h
GLP-1s like Ozempic are among the most important drug breakthroughs ever
The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier ...
HR Dive
6h
Employees are asking about GLP-1 coverage. What should employers do?
For GLP-1 treatment in particular, employers “need to make sure the coverage is married with a patient engagement program, ...
Opinion
6d
Opinion
The Breakthrough Drug to Conquer Addiction: Ozempic?
Early data suggests GLP-1 drugs, renowned for their ability to assist in weight loss, may have a powerful effect on treating ...
The Economist
1d
It’s not just obesity. Drugs like Ozempic will change the world
Already one in eight American adults has been on
glp-1
drugs. Novo Nordisk, maker of semaglutide, branded
Ozempic
for ...
1d
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
Healthline
3d
How Ozempic, GLP-1 Weight Loss Drugs Affect the Brain to Curb Substance Misuse
A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...
15h
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback